Nutrien reports its Q2 2026 results today with a clear signal from inside the company: executives have been buying the stock through a prolonged slide.
The insider buying pattern here is unusually consistent. CFO Mark Thompson made at least five separate open-market purchases between late May and mid-June, paying between C$90 and C$95 per share. CEO Ken Seitz added 3,900 shares on May 8 at C$94.52, a transaction worth roughly US$269,000. A director picked up nearly 14,500 shares on the same date for close to US$1 million. Net insider buying over the past 90 days totals around US$1.8 million across more than 26,700 shares — and the stock has drifted lower since those purchases, closing at C$93.88 on Wednesday after falling 5.3% on the week. The insiders were buying at higher prices and are sitting on paper losses heading into the print.
The broader debate around Nutrien centres on whether potash pricing and demand can recover enough to justify the current valuation. Bears point to persistent pricing pressure in the global potash market and softening agricultural demand — the same forces that dragged the stock 7.3% on the day of the Q1 report in May, with a further 3.4% five-day loss following that release. Bulls lean on Nutrien's position as the world's largest fertilizer producer, a P/E multiple of roughly 12.9x and EV/EBITDA near 6.9x that leave room for re-rating, and a dividend yield running at about 3.2% — a factor score that ranks in the 92nd percentile of the ORTEX universe. EPS momentum, however, tells a more cautious story: the 30-day reading ranks in just the 18th percentile, and the 90-day reading is in the 30th, suggesting estimate revisions have been heading the wrong way.
The short-selling community is not pressing hard on Nutrien. Short interest is low at under 1% of the free float, and the lending market is exceptionally loose — availability is running above 5,000%, meaning there is far more supply in the borrow pool than current demand can absorb. Cost to borrow has also eased sharply, falling around 25% over the past month to roughly 0.5%. That picture argues against any meaningful short squeeze or borrow-driven pressure into the print. Peers are broadly weak on the week — CF Industries fell 5% and Yara International dropped 4.4% — suggesting sector-wide sentiment is the headwind rather than anything company-specific.
The earnings report will test whether management's own conviction, expressed through repeated open-market buying at prices above where the stock trades today, is vindicated by a Q2 result that arrests the slide in forward estimates.
See the live data behind this article on ORTEX.
Open NTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
